BIOMAT Database Logo BIOMAT Database Logo

Lack of correlation between IGFBP7 expression and BRAF mutational status in melanoma. 2010

David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D048493 Proto-Oncogene Proteins B-raf A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2. B-raf Kinase,BRAF Kinase,B-raf Kinases,BRAF Kinases,Proto-Oncogene Protein B-raf,B raf Kinase,B raf Kinases,B-raf, Proto-Oncogene Protein,B-raf, Proto-Oncogene Proteins,Kinase, B-raf,Kinase, BRAF,Protein B-raf, Proto-Oncogene,Proteins B-raf, Proto-Oncogene,Proto Oncogene Protein B raf,Proto Oncogene Proteins B raf
D018969 Insulin-Like Growth Factor Binding Proteins A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (Int J Gynaecol Obstet 1992;39(1):3-9) IGF Binding Protein,IGF-Binding Protein,IGF-Binding Proteins,IGFBP,Insulin-Like Growth Factor Binding Protein,Somatomedin-Binding Protein,Somatomedin-Binding Proteins,Binding Protein, IGF,IGF Binding Proteins,Insulin Like Growth Factor Binding Protein,Protein, IGF Binding,Protein, IGF-Binding,Protein, Somatomedin-Binding,Somatomedin Binding Protein,Somatomedin Binding Proteins

Related Publications

David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma.
June 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Psychological impact of BRAF mutational status in advanced melanoma patients.
April 2022, Italian journal of dermatology and venereology,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
[Mutational status of BRAF and histopathological characteristics in cutaneous malignant melanoma].
January 2019, Medicina,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status.
April 2017, Journal of the European Academy of Dermatology and Venereology : JEADV,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Impact of Reflex Testing for BRAF Mutational Status in Advanced Melanoma.
December 2022, Archives of pathology & laboratory medicine,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
High concordance of BRAF mutational status in matched primary and metastatic melanoma.
February 2019, Journal of cutaneous pathology,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
June 2015, JAMA oncology,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
June 2017, International journal of cancer,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
May 2018, Journal of the American Academy of Dermatology,
David Schrama, and Hermann Kneitz, and Christoph Willmes, and Christian Adam, and Roland Houben, and Jürgen C Becker
Error in Text. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
June 2015, JAMA oncology,
Copied contents to your clipboard!